ML18068A037
| ML18068A037 | |
| Person / Time | |
|---|---|
| Site: | 03037572 |
| Issue date: | 02/28/2018 |
| From: | Geoffrey Warren NRC/RGN-III |
| To: | Kritzman M Capital Cardiology, PC |
| References | |
| IR 2018001 | |
| Download: ML18068A037 (2) | |
See also: IR 07200201/1980001
Text
NRC FORM 591M PART 1
U.S. NUCLEAR REGULATORY COMMISSION
(07-2012)
1ocFR2.201
SAFETY INSPECTION REPORT AND COMPLIANCE INSPECTION
1. LICENSEE/LOCATION INSPECTED:
Capital Cardiology, P.C.
1200 E. Michigan Ave.
Lansing, Michigan 48912
REPORT NUMBER(S) 2018001
3. DOCKET NUMBER(S)
030-37572
LICENSEE:
2. NRC/REGIONAL OFFICE
Region III
U. S. Nuclear Regulatory Commission
2443 Warrenville Road, Suite 210
Lisle, IL 60532-4352
4. LICENSE NUMBER(S)
5. DATE(S) OF INSPECTION
21-32677-01
The inspection was an examination of the activities conducted under your license as they relate to radiation safety and to compliance with the Nuclear
Regulatory Commission (NRC) rules and regulations and the conditions of your license. The inspection consisted of selective examinations of
procedures and representative records, interviews with personnel, and observations by the inspector. The inspection findings are as follows:
~
Based on the inspection findings, no violations were identified.
D 2.
Previous violation(s) closed.
D 3.
D4.
The violations(s), specifically described to you by the inspector as non-cited violations, are not being cited because they were self-identified,
non-repetitive, and corrective action was or is being taken, and the remaining criteria in the NRC Enforcement Policy, to exercise
discretiol), were satisfied.
Non-cited violation(s) were discussed involving the following requirement(s):
During this inspection, certain of your activities, as described below and/or attached, were in violation of NRC requirements and are being
cited in accordance with NRC Enforcement Policy. This form is a NOTICE OF VIOLATION, which may be subject to posting in accordance
with 10 CFR 19.11.
(Violations and Corrective Actions)
Statement of Corrective Actions
I hereby state that, within 30 days, the actions described by me to the Inspector will be taken to correct the violations identified. This statement of
corrective actions is made in accordance with the requirements of 10 CFR 2.201 (corrective steps already taken, corrective steps which will be taken,
date when full compliance will be achieved). I understand that no further written response to NRC will be required, unless specifically requested.
TITLE
PRINTED NAME
SIGNATURE
DATE
LICENSEE'S
REPRESENTATIVE
NRC INSPECTOR
Geoffrey Warren, Sr. HP
BRANCH CHIEF
NRC FORM 591M PART 1 (07-2012)
hV-
NRC FORM 591M PART 3
(07-2012)
U.S. NUCLEAR REGULATORY COMMISSION
Docket File Information
SAFETY INSPECTION REPORT AND COMPLIANCE INSPECTION
1. LICENSEE/LOCATION INSPECTED:
Capital Cardiology, P.C.
1200 E. Michigan Ave.
Lansing, Michigan 48912
REPORT NUMBER(S) 2018001
3. DOCKET NUMBER(S)
030-37572
6. INSPECTION PROCEDURES USED
87130
2. NRG/REGIONAL OFFICE
Region III
U. S. Nuclear Regulatory Commission
2443 Warrenville Road, Suite 210
Lisle, IL 60532:.4352
4. LICENSE NUMBER(S)
21-32677-01
7. INSPECTION FOCUS AREAS
03.01 - 03.09
5. DATE(S) OF INSPECTION
February 28, 2018
SUPPLEMENTAL INSPECTION INFORMATION
1. PROGRAM CODE(S)
02201
2. PRIORITY
5
I{] Main Office Inspection
D Field Office Inspection
D Temporary Job Site Inspection
3. LICENSEE CONTACT
4. TELEPHONE NUMBER
Michelle Kritzman, M.S., RSO
(734) 637-2408
Next Inspection Date:
02/28/2023
PROGRAM SCOPE
This was an unannounced routine inspection. The licensee was a cardiology clinic located in Lansing, Michigan, with
authorization to use byproduct materials in 10 CPR 35.200 only. The nuclear medicine department was staffed with one
full-time nuclear medicine technologist, who typically administered 120 diagnostic doses monthly, limited to cardiac
stress tests. The department received unit doses as needed from a licensed nuclear pharmacy. All waste was either held
for decay-in-storage (DIS) or returned to the nuclear pharmacy.
Performance Observations: The inspector observed one diagnostic administration of licensed materials, including dose
preparation and disposal. The technologist demonstrated survey meter and wipe counter QC, dose calibrator constancy,
package receipt surveys and wipes, daily and weekly contamination surveys, and other procedures. The inspector noted
no concerns with these activities. Review of dosimetry records indicated no exposures of regulatory concern. Interviews
with licensee personnel indicated adequate knowledge of radiation safety concepts and procedures. The inspector
performed independent and confirmatory radiation measurements which indicated results consistent with licensee survey
records and postings.
No violations were identified during this inspection.
NRG FORM 591M PART 3 (07-2012)